Website profile

Bioprocess International

BioProcess International magazine covers the whole bioprocessing industry: biotherapeutic process and product development and biomanufacturing.

  • 21articles · 30d
  • 2+ day agolatest article
  • Aug 17, 2026earliest in window
  • 100%with images
  • 322avg words
articles per day
Categories
  • Business & Industrial 16
  • Economy, Business & Finance 11
  • Industrial 9
  • Science & Nature 8
  • Science & Technology 6
  • Health & Wellness 5
  • Health 4
  • Finance & Business 2

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioProcess International
bioprocessintl.com > event-report > ebook-bioprocess-international-theater-at-bio-2026-shaping-the-future-of-biologics-manufacturing

BPI Theater at BIO 2026: Future of Biologics Manufacturing

2+ week, 5+ day ago   (83+ words) Click below to begin your download. Sponsored by Bora Biologics, Catalent, Enzene, Evotec, KBI Biopharma, Rentschler Biopharma, Rezon Bio, Samsung Biologics, Syngene, Thermo Fisher Scientific, Wheeler Bio Download now to access comprehensive summaries of presentations, panels, and the latest news…...

BioProcess International
bioprocessintl.com > business > yapan-bio-to-become-piramal-subsidiary-following-acquisition

Yapan Bio to become Piramal subsidiary following acquisition

3+ week, 3+ day ago   (221+ words) Yapan Bio’s range of services will help to advance PPL’s biologic development and manufacturing. According to Yapan Bio’s website, the company specializes in gene therapy, monoclonal antibodies (mAbs), and therapeutic proteins. It also claims expertise in process development and optimization,…...

BioProcess International
bioprocessintl.com > business > henlius-and-sandoz-announce-global-biosimilar-commercialization-partnership

Henlius, Sandoz partner on up to 10 biosimilar products

3+ week, 4+ day ago   (251+ words) The initial agreement covers biosimilars of cetuximab, evolocumab, and belimumab with more products in the pipeline. Shanghai Henlius Biotech announced the signing of a strategic collaboration with big biosimilar maker Sandoz to partner on up to 10 biosimilar assets, many of…...